Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

Namki Hong, Yong-ho Lee, Kenichi Tsujita, Jorge A. Gonzalez, Christopher M. Kramer, Tomas Kovarnik, George N. Kouvelos, Hiromichi Suzuki, Kyungdo Han, Chan Joo Lee, Sung Ha Park, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang

Endocrinol Metab. 2018;33(2):219-227. Published online May 4, 2018
DOI: https://doi.org/10.3803/EnM.2018.33.2.219

Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

Endocrinology and Metabolism. 2018;33(2):219

Link1 Link2 Link3

Ezetimibe/statin combination therapy to treat patients with type 2 diabetes

Michel Farnier

Atherosclerosis Supplements. 2015;17:2-8

Link1 Link2

Differential association of ezetimibe-simvastatin combination with major adverse cardiovascular events in patients with or without diabetes: a retrospective propensity score-matched cohort study

Yong-ho Lee, Namki Hong, Chan Joo Lee, Sung Ha Park, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang

Scientific Reports. 2018;8(1):

Link1

Link2 Link3

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

L. A. Leiter, D. J. Betteridge, M. Farnier, J. R. Guyton, J. Lin, A. Shah, A. O. Johnson-Levonas, P. Brudi

Diabetes, Obesity and Metabolism. 2011;13(7):615-628

Link1 Link2

Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials

Tiansheng Wang, Fei Wang, Junwen Zhou, Huilin Tang, Sharon Giovenale

Diabetes/Metabolism Research and Reviews. 2016;32(8):843-857

Link1 Link2

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients

Sean L Zheng, Alistair J Roddick, Salma Ayis

Diabetes and Vascular Disease Research. 2017;14(5):400-406

Link1 Link2 Link3

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes

John R Guyton, D John Betteridge, Michel Farnier, Lawrence A Leiter, Jianxin Lin, Arvind Shah, Amy O Johnson-Levonas, Philippe Brudi

Diabetes and Vascular Disease Research. 2011;8(2):160-172

Link1 Link2

172: Combination therapy for mixed dyslipidemia and its effects on multiple lipids: Niacin extended release + statin versus ezetimibe + statin

Journal of Clinical Lipidology. 2008;2(5):S79-S80

Link1 Link2

Bupropion and/or naltrexone are not associated with increased risk of major adverse cardiovascular events: A network meta-analysis of additive effects

L.S.F. De Carvalho, B.M. Luchiari, I. Bonilha, A. Sposito

Atherosclerosis. 2020;315:e9

Link1 Link2

Ezetimibe–Statin Combination to Reduce Cardiovascular Events: The Evidence Base

Ishwarlal Jialal, Nicola Abate

Metabolic Syndrome and Related Disorders. 2015;13(8):327-328

Link1 Link2